JMP Securities reiterated coverage on Ocular Therapeutix with a new price target

3/1/22 7:05:45 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $OCUL alert in real time by email

JMP Securities reiterated coverage of Ocular Therapeutix with a rating of Market Outperform and set a new price target of $22.00 from $30.00 previously

Get the next $OCUL alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OCUL

Date	Price Target	Rating	Analyst
4/8/2025		Outperform	William Blair
3/18/2025	$17.00	Outperform	RBC Capital Mkts
3/11/2025	$15.00	Buy	Needham
10/16/2024		Sector Outperform	Scotiabank
6/20/2024	$7.00 → $11.00	Hold → Buy	TD Cowen
5/31/2024	$15.00	Overweight	Piper Sandler
2/9/2024	$15.00	Buy	BofA Securities
4/21/2023	$18.00	Outperform	Robert W. Baird

More analyst ratings

JMP Securities reiterated coverage on Ocular Therapeutix with a new price target

Chat with this insight

Recent Analyst Ratings for
$OCUL

$OCUL
SEC Filings

SEC Form S-8 filed by Ocular Therapeutix Inc.

Ocular Therapeutix Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

SEC Form 10-Q filed by Ocular Therapeutix Inc.

$OCUL
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Lindstrom Richard L Md bought $69,600 worth of shares (10,000 units at $6.96), increasing direct ownership by 6% to 172,704 units (SEC Form 4)

Summer Road Llc bought $7,000,000 worth of shares (930,851 units at $7.52) (SEC Form 4)

Summer Road Llc bought $4,999,998 worth of shares (1,538,461 units at $3.25) (SEC Form 4)

JMP Securities reiterated coverage on Ocular Therapeutix with a new price target

Chat with this insight

Recent Analyst Ratings for $OCUL

$OCUL SEC Filings

SEC Form S-8 filed by Ocular Therapeutix Inc.

Ocular Therapeutix Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

SEC Form 10-Q filed by Ocular Therapeutix Inc.

$OCUL Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Lindstrom Richard L Md bought $69,600 worth of shares (10,000 units at $6.96), increasing direct ownership by 6% to 172,704 units (SEC Form 4)

Summer Road Llc bought $7,000,000 worth of shares (930,851 units at $7.52) (SEC Form 4)

Summer Road Llc bought $4,999,998 worth of shares (1,538,461 units at $3.25) (SEC Form 4)

Recent Analyst Ratings for
$OCUL

$OCUL
SEC Filings

$OCUL
Insider Purchases